Deutsche Bank’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-418,975
| Closed | -$19.9M | – | 3623 |
|
|
2025
Q3 | $19.9M | Buy |
418,975
+76,977
| +23% | +$3.73M | 0.01% | 858 |
|
|
2025
Q2 | $18.2M | Buy |
341,998
+107,868
| +46% | +$4.9M | 0.01% | 855 |
|
|
2025
Q1 | $9.48M | Sell |
234,130
-39,681
| -14% | -$1.68M | ﹤0.01% | 1026 |
|
|
2024
Q4 | $7.62M | Sell |
273,811
-61,807
| -18% | -$1.87M | ﹤0.01% | 1133 |
|
|
2024
Q3 | $9.63M | Buy |
335,618
+9,571
| +3% | +$250K | ﹤0.01% | 1023 |
|
|
2024
Q2 | $7.65M | Sell |
326,047
-708
| -0.2% | -$15.1K | ﹤0.01% | 1084 |
|
|
2024
Q1 | $8.25M | Buy |
326,755
+136,544
| +72% | +$3.28M | ﹤0.01% | 1091 |
|
|
2023
Q4 | $4.44M | Buy |
190,211
+79,612
| +72% | +$1.57M | ﹤0.01% | 1302 |
|
|
2023
Q3 | $5.59M | Sell |
110,599
-63,951
| -37% | -$2.98M | ﹤0.01% | 1005 |
|
|
2023
Q2 | $8.15M | Sell |
174,550
-345,025
| -66% | -$15.8M | ﹤0.01% | 1057 |
|
|
2023
Q1 | $19.9M | Buy |
519,575
+91,892
| +21% | +$4.1M | 0.01% | 761 |
|
|
2022
Q4 | $23.4M | Buy |
427,683
+414,957
| +3,261% | +$17.8M | 0.01% | 720 |
|
|
2022
Q3 | $433K | Sell |
12,726
-2,037
| -14% | -$31.2K | ﹤0.01% | 2452 |
|
|
2022
Q2 | $139K | Sell |
14,763
-1,768
| -11% | -$18.4K | ﹤0.01% | 3354 |
|
|
2022
Q1 | $234K | Sell |
16,531
-1,640
| -9% | -$28.7K | ﹤0.01% | 3177 |
|
|
2021
Q4 | $384K | Sell |
18,171
-18,796
| -51% | -$417K | ﹤0.01% | 2995 |
|
|
2021
Q3 | $826K | Sell |
36,967
-1,078
| -3% | -$24.4K | ﹤0.01% | 2736 |
|
|
2021
Q2 | $944K | Buy |
38,045
+7,916
| +26% | +$222K | ﹤0.01% | 2800 |
|
|
2021
Q1 | $874K | Sell |
30,129
-35,926
| -54% | -$1.09M | ﹤0.01% | 2748 |
|
|
2020
Q4 | $1.7M | Sell |
66,055
-53,936
| -45% | -$1.5M | ﹤0.01% | 2041 |
|
|
2020
Q3 | $3.69M | Buy |
119,991
+63,277
| +112% | +$2.21M | ﹤0.01% | 1400 |
|
|
2020
Q2 | $1.41M | Buy |
56,714
+54,009
| +1,997% | +$1.23M | ﹤0.01% | 2005 |
|
|
2020
Q1 | $57K | Buy |
2,705
+1,014
| +60% | +$21.7K | ﹤0.01% | 3480 |
|
|
2019
Q4 | $37K | Buy |
1,691
+374
| +28% | +$7.74K | ﹤0.01% | 4083 |
|
|
2019
Q3 | $29K | Buy |
+1,317
| New | +$30.6K | ﹤0.01% | 4180 |
|
Other funds holding AKRO
Deutsche Bank's AKRO Position: Q4 2025 in Review
Deutsche Bank sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 418,975 shares — an estimated $19.9M sold.
Deutsche Bank first reported a position in AKRO in Q3 2019 and held it in 25 quarters. The position peaked at $23.4M in Q4 2022. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.
- Deutsche Bank reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
- Deutsche Bank sold 418,975 Akero Therapeutics shares in Q4 2025, an estimated $19.9M.
- Deutsche Bank first reported a position in Akero Therapeutics in Q3 2019 and held it in 25 quarters.
- Deutsche Bank's Akero Therapeutics position peaked at $23.4M in Q4 2022.
- 2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.
Based on Deutsche Bank's 13F filing for Q4 2025, filed 11 Feb 2026.